Data / New clinical trials / Dyslipidemias

New Dyslipidemias clinical trials: 153 posted since Nov 2024

Name: New Dyslipidemias clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Dyslipidemias clinical trials: 153 rows for $7.65, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 4 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/dyslipidemias, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

153 clinical studies in dyslipidemias were first posted on ClinicalTrials.gov from November 19, 2024 to November 9, 2026; 49 have an industry sponsor and 88 are recruiting or about to. The newest, NCT07924345, was posted on November 9, 2026: Observational Study to Evaluate Achieving LDL-cholesterol Target Level to Treat With Rovazet Tab. With... (HK inno.N Corporation).

The request: Every new Dyslipidemias clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

153New trials
49Industry sponsored
88Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 153, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07924345	Observational Study to Evaluate Achieving LDL-cholesterol Target Level to Treat With Rovazet Tab. With Dyslipidemia Patients	HK inno.N Corporation	Observational	Recruiting	Dyslipidemia	6,713	South Korea	clinicaltrials.gov
November 5, 2026	NCT07919158	Impact of Dyslipidemia on Metabolic Health of Adults With Overweight/Obesity (IDOM): A Study at the San Raffaele Hospital Center for...	Rovere Querini Patrizia	Observational	Active not recruiting	Dyslipidemia, Obesity & Overweight	900	Italy	clinicaltrials.gov
November 4, 2026	NCT07917676	Multimodal AI-Driven Out-of-Hospital Management for Hypertension and Cardiometabolic Risk	China National Center for Cardiovascular Diseases	Not applicable	Not yet recruiting	Hypertension, Hyperglycemia, Dyslipidemia	150		clinicaltrials.gov
November 4, 2026	NCT07917364	Asprosin and miRNA Expression in Young Women With Metabolic Syndrome	University of Applied Sciences in Nowy Targ	Observational	Recruiting	Metabolic Syndrome, Insulin Resistance, Obesity, Abdominal, Dyslipidemias	110	Poland	clinicaltrials.gov
November 4, 2026	NCT07915687	Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health	Universiti Teknologi Mara	Phase 2	Not yet recruiting	Dyslipidemia	190	Malaysia	clinicaltrials.gov
November 2, 2026	NCT07909915	Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular...	Rehman Medical Institute - RMI	Phase 4	Not yet recruiting	Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia, Stroke (CVA) or TIA, Cardio Vascular Disease	178	Pakistan	clinicaltrials.gov
November 2, 2026	NCT07908433	Study of the Safety and Efficacy of Prenofitol Tablets	Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation	Phase 2	Not yet recruiting	Dyslipidemia	160		clinicaltrials.gov
October 26, 2026	NCT07894887	EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)	Editas Medicine, Inc.	Phase 1/2	Not yet recruiting	Heterozygous Familial Hypercholesterolemia (HeFH)	56	Australia	clinicaltrials.gov
October 21, 2026	NCT07884903	Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks	Shanxi Bethune Hospital	Observational	Not yet recruiting	Obesity & Overweight, Diabetes Mellitus, Type 2, Hypertension, Non-alcoholic Fatty Liver Disease (MASLD)...	25,974	China	clinicaltrials.gov
October 19, 2026	NCT07880717	Prevalence and Associated Factors of High BMI and Periodontitis in Thai Adults Aged Under 60 Years	Mahidol University	Observational	Recruiting	Diabete Mellitus, Dyslipidaemia, Chronic Kidney Disease, Psychiatric Disorder, Hypertension, Hypothyroidism, Smoking...	93	Thailand	clinicaltrials.gov
October 16, 2026	NCT07879144	Digital Nudges to Improve Heart Health Actions After Community Screening in Malaysia (NADI-MyHeartRisk)	Cardiovascular Advancement and Research Excellence Institute	Not applicable	Not yet recruiting	Cardiovascular Diseases, Cardiovascular Risk Factor	6,588	Malaysia	clinicaltrials.gov
October 13, 2026	NCT07871565	Time-Restricted Eating With or Without Energy Restriction in Dyslipidemic Women With Owerweight or Obesity	Acibadem University	Not applicable	Completed	Dyslipidemia, Obesity & Overweight	56	Turkey (Türkiye)	clinicaltrials.gov
September 28, 2026	NCT07845448	A Cluster-Randomized Controlled Trial	Second Affiliated Hospital of Nanchang University	Not applicable	Not yet recruiting	Hypertension, Stroke, Cardiovascular, Coronary Heart Disease, Ischemic Heart Disease, Dyslipidaemia, Diabete Mellitus...	14,400		clinicaltrials.gov
September 25, 2026	NCT07843238	Evaluation of a New Virtual Care Pathway for Older Adults With Noncommunicable Diseases	National University of Malaysia	Not applicable	Recruiting	Hypertension (HTN), Diabetes, Dyslipidaemia	160	Malaysia	clinicaltrials.gov
September 22, 2026	NCT07835282	Germany on Target Registry	Deutsche Gesellschaft für Lipidologie e. V. (DGFL) - Lipid-Liga	Observational	Not yet recruiting	Myocardial Infarction (MI), Dyslipidemias	10,000		clinicaltrials.gov
September 18, 2026	NCT07828990	Cardiovascular Risk Factors and Lipid Profile in Hospitalized Mexican Adults	Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo	Observational	Completed	Dyslipidemia	107	Mexico	clinicaltrials.gov
September 17, 2026	NCT07824323	Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome	Taipei Medical University Hospital	Phase 4	Recruiting	Acute Coronary Syndromes, Dyslipidemia	400	Taiwan	clinicaltrials.gov
September 2, 2026	NCT07799129	Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia	Eddingpharm (Zhuhai) Co., Ltd.	Phase 2	Not yet recruiting	Mixed Dyslipidemia	144	China	clinicaltrials.gov
August 24, 2026	NCT07781371	A Retrospective Real-World Cohort Study	Novo Nordisk A/S	Observational	Active not recruiting	Obesity, Type 2 Diabetes (T2D), Prediabetes, Cardiovascular Disease (CVD), Dyslipidemia, Metabolic...	100,000	Denmark	clinicaltrials.gov
August 20, 2026	NCT07777003	A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10582 in Healthy Subjects and Subjects With Mildly...	Jiangsu Hansoh Pharmaceutical Co., Ltd.	Phase 1	Not yet recruiting	Dyslipidemia	76		clinicaltrials.gov
July 27, 2026	NCT07729553	Vitamin D Status and Lipid Profile in Obese Adults With Type 2 Diabetes	Sinai University	Observational	Not yet recruiting	Type 2 Diabetes Mellitus, Obesity, Dyslipidemia, Vitamin D Deficiency	150		clinicaltrials.gov
July 24, 2026	NCT07726368	Study of ECC4703 With Sulfasalazine and Pitavastatin	Eccogene	Phase 1	Recruiting	Non-alcoholic Fatty Liver Disease (NAFLD), Dyslipidaemia	40	Australia	clinicaltrials.gov
July 20, 2026	NCT07715461	Effect of macaúba Oil Combined With Green Exercises	Federal University of Minas Gerais	Not applicable	Not yet recruiting	Stress Mental, Dyslipidemia, Obesity & Overweight	60	Brazil	clinicaltrials.gov
July 17, 2026	NCT07712367	Atorvastatin Plus Escitalopram for Depression With Dyslipidemia	Hengshui City Seventh People's Hospital	Observational	Completed	Depressive Episode, Dyslipidemia	60	China	clinicaltrials.gov
July 17, 2026	NCT07710261	Effects of Policosanol and Exercise on Fitness and Lipids in People With Elevated Blood Lipids	Mahidol University	Not applicable	Not yet recruiting	Dyslipidemia, Elevated Blood Lipids, Physical Fitness, Exercise Training, Muscle Function, Handgrip Strength Test	120	Thailand	clinicaltrials.gov
July 16, 2026	NCT07707778	Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV	National Taiwan University Clinical Trial Center	Phase 4	Enrolling by invitation	Human Immunodeficiency Virus (HIV), Metabolic Dysfunction Associated Steatotic Liver Disease, Dyslipidaemia, Diabetes...	60	Taiwan	clinicaltrials.gov
July 14, 2026	NCT07703371	Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome	JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH	Not applicable	Recruiting	Obesity & Overweight, Metabolic Syndrome, Gut Dysbiosis, Insulin Resistance, Dyslipidemia	50	India	clinicaltrials.gov
July 10, 2026	NCT07696403	Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose	University of Georgia	Not applicable	Not yet recruiting	Nutrition, Healthy, Dyslipidemia, Overweight and Obesity	90	United States	clinicaltrials.gov
July 9, 2026	NCT07692438	Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD	Taipei Medical University	Not applicable	Recruiting	Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-alcoholic Fatty Liver Disease NAFLD, Dyslipidemia...	60	Taiwan	clinicaltrials.gov
July 8, 2026	NCT07691268	Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions	Korea United Pharm. Inc.	Phase 1	Completed	Dyslipidemia	44	South Korea	clinicaltrials.gov
July 6, 2026	NCT07685639	Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement...	University of Alberta	Not applicable	Recruiting	ACS (Acute Coronary Syndrome), Hyperlipidemia, Dyslipidemia, Low-Density-Lipoprotein-cholesterol Level	2,000	Canada	clinicaltrials.gov
July 6, 2026	NCT07682948	A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and...	Korea United Pharm. Inc.	Phase 1	Recruiting	Hypertension, Dyslipidemia	36	South Korea	clinicaltrials.gov
July 2, 2026	NCT07682285	Taiwanese Green Propolis for Lipid Profiles, Fatigue, and Quality of Life in Oral Cavity Cancer Survivors	Taipei Medical University	Not applicable	Completed	Head and Neck Squamous Cell Carcinoma, Cancer-related Fatigue, Dyslipidemias	25	Taiwan	clinicaltrials.gov
July 1, 2026	NCT07679828	Polypills Approach for Multiple Cardiovascular Risk Factors	China Medical University, China	Not applicable	Recruiting	Hypertension, Dyslipidemia, Diabetes	8,252	China	clinicaltrials.gov
June 25, 2026	NCT07668791	The Efficacy of a Food Supplement Consisting of the Combination of an Olive Extract and a Myrtle Extract for the Improvement of Lipid...	Labomar SPA	Not applicable	Completed	Dyslipidaemias	112	Italy	clinicaltrials.gov
June 18, 2026	NCT07655960	To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults	AJU Pharm Co., Ltd.	Phase 1	Completed	Hypercholesterolemia, Dyslipidemia	41	South Korea	clinicaltrials.gov
June 16, 2026	NCT07649577	Generative AI for Medication Counselling and Adherence in Community Pharmacies	University of Petra	Not applicable	Completed	Hypertension, Diabetes Mellitus, Dyslipidemias, Cardiovascular Diseases, Pulmonary Disease, Chronic Obstructive...	136	Jordan	clinicaltrials.gov
June 12, 2026	NCT07644910	Nudging Preventive Screening Via Message Framing and Bundling	University of Chile	Not applicable	Not yet recruiting	Breast Neoplasms, Uterine Cervical Neoplasms, Colorectal Neoplasms, Prostatic Neoplasms, Diabetes Mellitus...	235,000		clinicaltrials.gov
June 8, 2026	NCT07634510	Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205	Shanghai Minwei Biotechnology Co., Ltd	Phase 1	Not yet recruiting	Dyslipidemias	37		clinicaltrials.gov
June 4, 2026	NCT07627555	Polyunsaturated Fatty Acids-based Bars Effect on Metabolic Syndrome Patients	University of Lahore	Not applicable	Completed	Dyslipidemia, Metabolic Syndrome (MetS)	60	Pakistan	clinicaltrials.gov
June 3, 2026	NCT07622433	A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus...	AstraZeneca	Phase 1	Completed	Healthy Participants	18	United States	clinicaltrials.gov
June 1, 2026	NCT07616570	Serum Adipokines and Metabolic Parameters With Hormone Replacement in Newly Diagnosed Hypothyroidism	Başakşehir Çam & Sakura City Hospital	Observational	Completed	Hypothyroidism, Primary Hypothyroidism, Metabolic Syndrome	88	Turkey (Türkiye)	clinicaltrials.gov
May 29, 2026	NCT07614659	Uppsala Self-Screening of Cardiovascular Health	Johan Sundström	Not applicable	Recruiting	Cardiovascular Diseases, Hypertension, Dyslipidemias, Diabetes Mellitus, Atrial Fibrillation, Chronic Kidney Disease	45,000	Sweden	clinicaltrials.gov
May 27, 2026	NCT07610304	Effect of Alpha Tocopherol and Psyllium on Lipid Levels in Dyslipidaemia Patients	NUR International University	Phase 2	Completed	Dyslipidaemia	60	Pakistan	clinicaltrials.gov
May 15, 2026	NCT07590167	A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C	Addpharma Inc.	Phase 1	Not yet recruiting	Dyslipidemia, Hypertension	60	South Korea	clinicaltrials.gov
May 14, 2026	NCT07588256	New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases	New Taipei City Medical Association	Not applicable	Recruiting	Microalbuminuria, Microalbuminuria /Creatinine Ratios ACR, Cardiovascular Disease Risk Factor, Cardiovascular Disease...	4,162	Taiwan	clinicaltrials.gov
May 12, 2026	NCT07581028	Bioequivalence Study of AJU-C715 and C715R in Healthy Adult Volunteers	AJU Pharm Co., Ltd.	Phase 1	Completed	Hypercholerolemia, Dyslipidemia	61	South Korea	clinicaltrials.gov
April 30, 2026	NCT07559110	Supplementation With Salicornia Extract Rich in Polyphenols (B-Salicornia) to Improve Vascular Health in Patients With Dyslipidemia Who Are...	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	Not applicable	Not yet recruiting	Dyslipidemia	250	Spain	clinicaltrials.gov
April 27, 2026	NCT07552571	Goal Commitment and Proactive Health Behavior in Chronic Disease Patients	Xiong Juyang	Not applicable	Recruiting	Hypertension, Diabetes Mellitus, Dyslipidemia	600	China	clinicaltrials.gov
April 27, 2026	NCT07551960	Pilot Validation of the STELA Preventive Medicine Platform to Reduce Modifiable Health Risk Factors in Adults (CPM-STELA)	Nemocnice AGEL Trinec-Podlesi a.s.	Not applicable	Enrolling by invitation	Cardiovascular Risk Factors, Insulin Resistance, Obesity, Dyslipidemias, Metabolic Syndrome	100	Czechia	clinicaltrials.gov
April 24, 2026	NCT07551505	Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)	Bisirna Therapeutics (Suzhou) Co., Ltd.	Phase 1	Active not recruiting	Dyslipidemias	40	China	clinicaltrials.gov
April 22, 2026	NCT07545005	Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth	Boston Children's Hospital	Not applicable	Not yet recruiting	Dyslipidemia, Hypertension, Obesity & Overweight	150	United States	clinicaltrials.gov
April 22, 2026	NCT07543718	Group Medical Visits for Patients With Dyslipidemia	Université de Sherbrooke	Not applicable	Recruiting	Dyslipidemias	288	Canada	clinicaltrials.gov
April 13, 2026	NCT07524101	Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD	Yonsei University	Not applicable	Recruiting	Renal Insufficiency, Atherosclerosis, Dyslipidemia, Hypercholesterolemia, Cardiovascular Diseases	1,952	South Korea	clinicaltrials.gov
April 13, 2026	NCT07523971	Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study	JW Pharmaceutical	Observational	Recruiting	Dyslipidemias	10,000	South Korea	clinicaltrials.gov
April 7, 2026	NCT07515573	Effect of Compound (Cardiol Forte) on Lipid And Glycemic Parameters in Low Cardiovascular Risk Individuals	U.G.A. Nutraceuticals	Not applicable	Not yet recruiting	Dyslipidemia	50	Italy	clinicaltrials.gov
April 7, 2026	NCT07515560	Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study	Daewoong Pharmaceutical Co. LTD.	Observational	Not yet recruiting	Dyslipidemia	12,000	South Korea	clinicaltrials.gov
April 7, 2026	NCT07513571	A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults	AstraZeneca	Phase 1	Completed	Healthy Participants	31	United States	clinicaltrials.gov
March 31, 2026	NCT07502703	Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores...	Tarumanagara University	Observational	Not yet recruiting	Dyslipidemia, Angina (Stable), Coronary Artery Disease (CAD), Heart Disease, Hypertension, Diabetes (DM)	300	Indonesia	clinicaltrials.gov
March 27, 2026	NCT07497776	Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome	National Institute of Kidney Disease and Urology (NIKDU)	Phase 4	Completed	Dyslipidaemia	100	Bangladesh	clinicaltrials.gov
March 25, 2026	NCT07492264	Evaluation of Food Supplementation in Subjects With Suboptimal Levels of LDL Cholesterol	Cooper Consumer Health	Not applicable	Completed	Dyslipidaemia	90	Italy	clinicaltrials.gov
March 24, 2026	NCT07491172	A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias	CRISPR Therapeutics AG	Phase 1	Recruiting	Cardiovascular, Metabolic Disease, Dyslipidemias, Lipid Disorder, Hypertriglyceridemia, Heterozygous Familial...	90	Australia, New Zealand, United Kingdom, United States	clinicaltrials.gov
March 24, 2026	NCT07489209	A Dose-exploration Study of EDP167 in HoFH	Eddingpharm (Zhuhai) Co., Ltd.	Phase 2	Recruiting	Homozygous Familial Hypercholesterolemia (HoFH)	20	China	clinicaltrials.gov
March 17, 2026	NCT07476703	Expanded Studies on the SCAPIS Stockholm Reexamination Cohort	Danderyd Hospital	Observational	Active not recruiting	Coronary Artery Disease, Arterial Stiffness, Blood Pressure, AORTIC VALVE DISEASES, Mitral Valve Stenosis and/or...	1,400	Sweden	clinicaltrials.gov
March 17, 2026	NCT07476248	The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association...	Assiut University	Observational	Not yet recruiting	Diabetic Nephropathy, Dyslipidemia	84		clinicaltrials.gov
March 16, 2026	NCT07474233	Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health	Liverpool John Moores University	Observational	Not yet recruiting	Atherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia, Endothelial Dysfunction	90	United Kingdom	clinicaltrials.gov
March 16, 2026	NCT07473843	Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia	Arrowhead Pharmaceuticals	Phase 3	Recruiting	Homozygous Familial Hypercholesterolemia	10	Denmark, Poland, United States	clinicaltrials.gov
March 12, 2026	NCT07468500	Real World Adherence of PCSK9 Targeted Therapy	Novartis Pharmaceuticals	Observational	Not yet recruiting	Dyslipidemia, Hypercholesterolemia	3,600		clinicaltrials.gov
March 10, 2026	NCT07462871	Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health	Liverpool John Moores University	Not applicable	Not yet recruiting	Atherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia	30	United Kingdom	clinicaltrials.gov
March 3, 2026	NCT07447362	Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study	Universidad Católica San Antonio de Murcia	Not applicable	Recruiting	Cardiovascular Risk Factors, Hypertension, Dyslipidemia, Type 2 Diabetes Mellitus, Obesity, Overweight, Tobacco Use	220	Chile	clinicaltrials.gov
March 3, 2026	NCT07445542	Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With...	JW Pharmaceutical	Observational	Completed	Hypercholesterolemia	6,927	South Korea	clinicaltrials.gov
February 20, 2026	NCT07423884	Effect of a Low-Calorie MCT-Rich Traditional Minangkabau Diet on Obese Individuals	Andalas University	Not applicable	Not yet recruiting	Metabolically Unhealty Obese, Dyslipidemia, Diabetes (DM), Resistance, Insulin, Obesity	40	Indonesia	clinicaltrials.gov
February 20, 2026	NCT07423598	A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in...	AstraZeneca	Phase 1	Completed	Healthy Participants	40	United States	clinicaltrials.gov
February 17, 2026	NCT07412457	Guideline Adherence in Dyslipidemia With Clinical Decision Support	I.M. Sechenov First Moscow State Medical University	Observational	Not yet recruiting	Dyslipidemia, Coronary Artery Disease, Atherosclerosis of Major Arteries, Cardiovascular Risk, Subclinical...	500	Russia	clinicaltrials.gov
February 17, 2026	NCT07412080	EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia	Eddingpharm (Zhuhai) Co., Ltd.	Phase 1	Completed	Healthy Adult Male and Female Volunteers, Mild Dyslipidemia	40	China	clinicaltrials.gov
February 10, 2026	NCT07401017	The Effects of Rosuvastatin on Running Training Adaptation and Safety	Taipei Medical University WanFang Hospital	Not applicable	Not yet recruiting	Dyslipidemia, Long-Distance Running, Endurance Training, Statin-Associated Muscle Symptoms	40	Taiwan	clinicaltrials.gov
February 4, 2026	NCT07387393	To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social...	University of Hawaii	Not applicable	Enrolling by invitation	Cardiometabolic Conditions, Hypertension (HTN), Dyslipidemia, Pre-diabetes, Type 2 Diabetes Mellitus (T2DM), Overweight...	400	United States	clinicaltrials.gov
January 28, 2026	NCT07373392	Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and...	Aalborg University	Not applicable	Not yet recruiting	Diabete Type 1, Diabete Type 2, Prediabetes	210	Denmark	clinicaltrials.gov
January 22, 2026	NCT07359105	Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)	Sin Gon Kim	Not applicable	Recruiting	Dyslipidemia Associated With Type II Diabetes Mellitus	2,186	South Korea	clinicaltrials.gov
January 20, 2026	NCT07350486	LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia	First Hospital of China Medical University	Not applicable	Active not recruiting	Hypertension, Diabetes, Dyslipidemia	6,800	China	clinicaltrials.gov
January 14, 2026	NCT07340580	Implementation Facilitation of Exercise is Medicine Greenville	University of South Carolina	Not applicable	Not yet recruiting	Physical Inactivity, Dyslipidemia, Obesity and Overweight, Hypertension, Diabetes, Health Care Delivery, Patients...	35	United States	clinicaltrials.gov
January 5, 2026	NCT07316608	A Phase I Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy...	AstraZeneca	Phase 1	Completed	Healthy Participants	44	United States	clinicaltrials.gov
January 2, 2026	NCT07314775	Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study	Xinjiang Uygur Pharmaceutical Co., Ltd.	Phase 4	Not yet recruiting	Dyslipidemia, Carotid Atherosclerotic Plaques	422		clinicaltrials.gov
December 30, 2025	NCT07310849	Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity	Chang Gung University of Science and Technology	Not applicable	Recruiting	Type2Diabetes, Hypertension, Dyslipidemia, CKD, Cardio Vascular Disease, Gout Arthritis	169	Taiwan	clinicaltrials.gov
December 29, 2025	NCT07308314	Taining Golden Lake Comprehensive Chronic Disease Management Initiative	First Affiliated Hospital of Fujian Medical University	Observational	Recruiting	Chronic Disease, Chronic Disease Management, Hypertension, Diabetes Mellitus, Dyslipidemias, Frailty, Sarcopenia	20,000	China	clinicaltrials.gov
December 23, 2025	NCT07298564	Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)	Behnood Abbasi	Not applicable	Recruiting	Polycystic Ovary Syndrome (PCOS)	84	Iran	clinicaltrials.gov
December 8, 2025	NCT07269795	Advanced Strategy of Food Supplements for the Optimization of Satiety and Lipid Metabolism in Maturity (SACIANS)	University of Alicante	Not applicable	Completed	Dyslipidemia, Lipid Metabolism, Satiety Response, Overweight and/or Obesity	80	Spain	clinicaltrials.gov
December 8, 2025	NCT07268781	Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients	Hasanuddin University	Not applicable	Completed	Diabetes Mellitus (DM), Dyslipidemia, Lipid Profile, Functional Food, Nutritional Intervention, Cardiovascular Risk...	102	Indonesia	clinicaltrials.gov
December 1, 2025	NCT07255820	Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol	Bahria University	Phase 4	Completed	Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol	126	Pakistan	clinicaltrials.gov
November 24, 2025	NCT07246408	Intermittent Cottonseed Oil Consumption	University of Georgia	Not applicable	Recruiting	Dyslipidemia, Overweight and Obesity, Nutrition, Healthy	75	United States	clinicaltrials.gov
November 20, 2025	NCT07238556	A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors	University of Connecticut	Not applicable	Recruiting	Hypertension, Dyslipidemia, Diabetes Mellitus, Obesity, Cardiovascular Disease	72	United States	clinicaltrials.gov
November 19, 2025	NCT07235046	A Study of DII235 in Adults With Elevated Lipoprotein(a)	Novartis Pharmaceuticals	Phase 2	Active not recruiting	Lipoprotein Disorder	234	China, Germany, Japan, United States	clinicaltrials.gov
October 27, 2025	NCT07221279	Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults	Kennesaw State University	Not applicable	Recruiting	Dyslipidemia, Insulin Resistance Syndrome, Hypertension, Inflammation Chronic, Obesity & Overweight	200	United States	clinicaltrials.gov
October 21, 2025	NCT07218900	A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels...	AstraZeneca	Phase 2	Completed	Dyslipidaemia	76	Russia	clinicaltrials.gov
October 14, 2025	NCT07216131	A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years	AstraZeneca	Phase 1	Completed	Healthy Participants	14	United States	clinicaltrials.gov
October 6, 2025	NCT07208331	Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Observational	Recruiting	Atherosclerotic Cardiovascular Disease (ASCVD), Hypertension, Dyslipidemia	750	Netherlands	clinicaltrials.gov
October 3, 2025	NCT07206875	Observational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine Disorders	IRCCS San Raffaele	Observational	Recruiting	Diabetes, Metabolic Disorders, Arterial Hypertension, Dyslipidemia, Liver Disease (Alcoholic or Not)	10,000	Italy	clinicaltrials.gov
September 26, 2025	NCT07194577	Effect of Moringa Oleifera Dehydrated Leaf Powder on the Components of Metabolic Syndrome in Mexican Adults.	Universidad de Colima	Not applicable	Completed	Nutritional and Metabolic Diseases, Metabolic Syndrome	36	Mexico	clinicaltrials.gov
September 17, 2025	NCT07178444	Evaluation of the Effectiveness of an Interdisciplinary Intervention After Acute Coronary Syndrome on Low-Density Lipoprotein Cholesterol...	Assistance Publique - Hôpitaux de Paris	Not applicable	Not yet recruiting	Acute Coronary Syndromes (ACS), Acute Coronary Syndromes	230	France	clinicaltrials.gov
September 16, 2025	NCT07175766	Dachundou No Sugar Added Soymilk for Lipid Modulation	National Taiwan Sport University	Not applicable	Completed	Dyslipidemias, Hypercholesterolemia, Cardiovascular Diseases	25	Taiwan	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
AstraZeneca	9	June 3, 2026
Eddingpharm (Zhuhai) Co., Ltd.	3	September 2, 2026
Korea United Pharm. Inc.	3	July 8, 2026
AJU Pharm Co., Ltd.	3	June 18, 2026
JW Pharmaceutical	3	April 13, 2026
Novartis Pharmaceuticals	3	March 12, 2026
Mahidol University	2	October 19, 2026
Jiangsu Hansoh Pharmaceutical Co., Ltd.	2	August 20, 2026
University of Georgia	2	July 10, 2026
Taipei Medical University	2	July 9, 2026
Daewoong Pharmaceutical Co. LTD.	2	April 7, 2026
Liverpool John Moores University	2	March 16, 2026
University of Toronto	2	April 9, 2025
HK inno.N Corporation	1	November 9, 2026
Rovere Querini Patrizia	1	November 5, 2026
China National Center for Cardiovascular Diseases	1	November 4, 2026
University of Applied Sciences in Nowy Targ	1	November 4, 2026
Universiti Teknologi Mara	1	November 4, 2026
Rehman Medical Institute - RMI	1	November 2, 2026
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation	1	November 2, 2026

By phase

Phase	New trials	Latest
Not applicable	73	November 4, 2026
Observational	33	November 9, 2026
Phase 1	24	August 20, 2026
Phase 2	8	November 4, 2026
Phase 4	8	November 2, 2026
Phase 3	4	March 16, 2026
Phase 1/2	2	October 26, 2026
Phase 2/3	1	February 19, 2025

By country

Country	New trials	Latest
South Korea	21	November 9, 2026
United States	19	July 10, 2026
China	17	October 21, 2026
Taiwan	9	September 17, 2026
Italy	8	November 5, 2026
Turkey (Türkiye)	5	October 13, 2026
Canada	5	July 6, 2026
United Kingdom	5	March 24, 2026
Malaysia	4	November 4, 2026
Pakistan	4	November 2, 2026
Mexico	4	September 18, 2026
Russia	4	February 17, 2026
Australia	3	October 26, 2026
Denmark	3	August 24, 2026
Sweden	3	May 29, 2026
Indonesia	3	March 31, 2026
Netherlands	3	October 6, 2025
Poland	2	November 4, 2026
Thailand	2	October 19, 2026
Brazil	2	July 20, 2026
Jordan	2	June 16, 2026
Spain	2	April 30, 2026
Japan	2	November 19, 2025
France	2	September 17, 2025
Portugal	2	March 17, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.